| Prevalence and incidence of Parkinson's disease in Europe S Von Campenhausen, B Bornschein, R Wick, K Bötzel, C Sampaio, ... European neuropsychopharmacology 15 (4), 473-490, 2005 | 994 | 2005 |
| Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study B Schramm, B Ehlken, A Smala, K Quednau, K Berger, D Nowak European Respiratory Journal 21 (1), 116-122, 2003 | 201 | 2003 |
| Cost of illness and its predictors for Parkinson’s disease in Germany AE Spottke, M Reuter, O Machat, B Bornschein, S von Campenhausen, ... Pharmacoeconomics 23, 817-836, 2005 | 200 | 2005 |
| The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers A Ihbe-Heffinger, B Ehlken, R Bernard, K Berger, C Peschel, HG Eichler, ... Annals of oncology 15 (3), 526-536, 2004 | 180 | 2004 |
| Health-related quality of life and healthcare utilisation in patients with Parkinson’s disease: impact of motor fluctuations and dyskinesias RC Dodel, K Berger, WH Oertel Pharmacoeconomics 19, 1013-1038, 2001 | 156 | 2001 |
| Costs of illness and care in Parkinson's disease: an evaluation in six countries S von Campenhausen, Y Winter, AR e Silva, C Sampaio, E Ruzicka, ... European Neuropsychopharmacology 21 (2), 180-191, 2011 | 137 | 2011 |
| Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study M Reuther, EA Spottke, J Klotsche, O Riedel, H Peter, K Berger, O Athen, ... Parkinsonism & related disorders 13 (2), 108-114, 2007 | 137 | 2007 |
| Untersuchung von Krankheitskosten bei Patienten mit Alzheimer-Erkrankung in Deutschland JF Hallauer, M Schons, A Smala, K Berger Gesundheitsökonomie und Qualitätsmanagement 5 (2), 73-9, 2000 | 136 | 2000 |
| Clinical outcomes and resource utilization associated with haemophilia care in Europe W Schramm, S Royal, B Kroner, E Berntorp, P Giangrande, C Ludlam, ... Haemophilia 8 (1), 33-43, 2002 | 135 | 2002 |
| Cost‐of‐illness in patients with moderate and severe chronic psoriasis vulgaris in Germany: Krankheitskosten bei Patienten mit mittelschwerer und schwerer chronischer Psoriasis … K Berger, B Ehlken, B Kugland, M Augustin JDDG: Journal der Deutschen Dermatologischen Gesellschaft 3 (7), 511-518, 2005 | 126 | 2005 |
| The socioeconomic impact of narcolepsy R Dodel, H Peter, T Walbert, A Spottke, C Noelker, K Berger, U Siebert, ... Sleep 27 (6), 1123-1128, 2004 | 124 | 2004 |
| Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus EA Spottke, J Volkmann, D Lorenz, P Krack, AM Smala, V Sturm, ... Journal of neurology 249, 759-766, 2002 | 102 | 2002 |
| Burden of oral mucositis: a systematic review and implications for future research K Berger, D Schopohl, A Bollig, D Strobach, C Rieger, D Rublee, ... Oncology research and treatment 41 (6), 399-405, 2018 | 81 | 2018 |
| Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective K Fischer, P Poonnoose, AL Dunn, P Babyn, MJ Manco‐Johnson, ... Haemophilia 23 (1), 11-24, 2017 | 81 | 2017 |
| Autologous blood donation in cardiac surgery: reduction of allogeneic blood transfusion and cost-effectiveness W Dietrich, K Thuermel, S Heyde, R Busley, K Berger Journal of cardiothoracic and vascular anesthesia 19 (5), 589-596, 2005 | 80 | 2005 |
| The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches TD Szucs, K Berger, DN Fisman, S Harbarth BMC infectious diseases 1, 1-7, 2001 | 69 | 2001 |
| Epidemiology and health economics of COPD across Europe: a critical analysis D Nowak, K Berger, B Lippert, K Kilgert, M Caeser, R Sandtmann Treatments in respiratory medicine 4, 381-395, 2005 | 68 | 2005 |
| Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany B Wefer, B Ehlken, J Bremer, H Burgdörfer, B Domurath, C Hampel, ... World journal of urology 28, 385-390, 2010 | 67 | 2010 |
| Cost effectiveness of haemophilia treatment: a cross-national assessment B Lippert, K Berger, E Berntorp, P Giangrande, M van den Berg, ... Blood coagulation & fibrinolysis 16 (7), 477-485, 2005 | 67 | 2005 |
| Haemophilia care in Europe: the ESCHQoL study W Schramm, A Gringeri, R Ljung, K Berger, A Crispin, M Bullinger, ... Haemophilia 18 (5), 729-737, 2012 | 65 | 2012 |
